((2S,4S)-4-benzyl-1-(8-cyclopropyl-2-methyl-9H-pyrimido[4,5-b]indol-4-yl)pyrrolidine-2,4-diyl)dimethanol

ID: ALA5092915

PubChem CID: 166631817

Max Phase: Preclinical

Molecular Formula: C27H30N4O2

Molecular Weight: 442.56

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(N2C[C@](CO)(Cc3ccccc3)C[C@H]2CO)c2c(n1)[nH]c1c(C3CC3)cccc12

Standard InChI:  InChI=1S/C27H30N4O2/c1-17-28-25-23(22-9-5-8-21(19-10-11-19)24(22)30-25)26(29-17)31-15-27(16-33,13-20(31)14-32)12-18-6-3-2-4-7-18/h2-9,19-20,32-33H,10-16H2,1H3,(H,28,29,30)/t20-,27-/m0/s1

Standard InChI Key:  BVQHFOQYLXZHKL-DCFHFQCYSA-N

Molfile:  

 
     RDKit          2D

 33 38  0  0  0  0  0  0  0  0999 V2000
   10.6978  -19.4310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1105  -18.7252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2929  -18.7207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1971  -15.0190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8601  -15.5011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6039  -16.2753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1458  -16.8822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9439  -16.7161    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1973  -15.9378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6538  -15.3342    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.7885  -16.2778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5387  -15.5021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7437  -15.3319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1976  -15.9366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4521  -16.7140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2466  -16.8805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9967  -15.7681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4895  -14.5580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6606  -13.7590    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8830  -14.0103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8943  -17.6592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1161  -17.9084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8888  -18.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3718  -18.3223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1890  -18.3258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5946  -19.0352    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1024  -20.1410    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8804  -19.4261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0655  -19.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6531  -20.1236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0578  -20.8345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8792  -20.8365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2880  -20.1313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  2  3  1  1
 11  6  1  0
  5  4  1  0
  4 12  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  9 17  1  0
 19 18  1  0
 20 19  1  0
 18 20  1  0
 13 18  1  0
 21 22  1  0
 22  2  1  0
  2 23  1  0
 23 24  1  0
 24 21  1  0
  7 21  1  0
 24 25  1  6
 25 26  1  0
  1 27  1  0
  3 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5092915

    ---

Associated Targets(Human)

PDK2 Tchem Pyruvate dehydrogenase kinase isoform 2 (894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 442.56Molecular Weight (Monoisotopic): 442.2369AlogP: 4.09#Rotatable Bonds: 6
Polar Surface Area: 85.27Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.22CX Basic pKa: 7.57CX LogP: 4.59CX LogD: 4.19
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.42Np Likeness Score: -0.09

References

1. Bessho Y, Akaki T, Hara Y, Yamakawa M, Obika S, Mori G, Ubukata M, Yasue K, Nakane Y, Terasako Y, Orita T, Doi S, Iwanaga T, Fujishima A, Adachi T, Ueno H, Motomura T..  (2021)  Structure-based drug design of novel and highly potent pyruvate dehydrogenase kinase inhibitors.,  52  [PMID:34808405] [10.1016/j.bmc.2021.116514]

Source